scholarly journals Impact of Serological and Histological Factors on Neurological Manifestations in Children and Adults with Celiac Disease

2021 ◽  
Vol 24 (2) ◽  
pp. 197
Author(s):  
Ramin Niknam ◽  
Seyed Reza Seraj ◽  
Mohammad Reza Fattahi ◽  
Mohammadali Nejati ◽  
Seyed-Mohsen Dehghani ◽  
...  
2016 ◽  
Vol 48 ◽  
pp. e242
Author(s):  
B. Parma ◽  
A. Di Cesare Merlone ◽  
L. Abbagnato ◽  
S. Barca ◽  
M.T. Ortisi

Cureus ◽  
2021 ◽  
Author(s):  
Saawan C Patel ◽  
Devarashetty Shreya ◽  
Diana I Zamora ◽  
Gautami S Patel ◽  
Idan Grossmann ◽  
...  

1989 ◽  
Vol 11 (5) ◽  
pp. 603???604 ◽  
Author(s):  
Zvi Ackerman ◽  
Sanchar Eliashiv ◽  
Avinoam Rechea ◽  
Joshep Zimmerman

2021 ◽  
pp. 282-289
Author(s):  
Youstina Hanna ◽  
Parul Tandon ◽  
Zane Gallinger

We report on the case of a 61-year-old male who initially presented with a progressive myoclonus and an intention tremor and was subsequently diagnosed with celiac disease. His neurological symptoms improved with anti-epileptic therapy and a gluten-free diet. Possible explanations include a milder disease phenotype or an epileptic component to his myoclonic movement disorder. This case highlights findings of a progressive myoclonic movement disorder, likely linked to celiac disease, and stresses the importance of a gluten-free diet in the management of the neurological manifestations of celiac disease.


Nutrients ◽  
2019 ◽  
Vol 11 (2) ◽  
pp. 380 ◽  
Author(s):  
Elizabeth Mearns ◽  
Aliki Taylor ◽  
Kelly Thomas Craig ◽  
Stefanie Puglielli ◽  
Daniel Leffler ◽  
...  

Celiac disease (CD) is an immune-mediated gastrointestinal disorder driven by innate and adaptive immune responses to gluten. Patients with CD are at an increased risk of several neurological manifestations, frequently peripheral neuropathy and gluten ataxia. A systematic literature review of the most commonly reported neurological manifestations (neuropathy and ataxia) associated with CD was performed. MEDLINE, Embase, the Cochrane Library, and conference proceedings were systematically searched from January 2007 through September 2018. Included studies evaluated patients with CD with at least one neurological manifestation of interest and reported prevalence, and/or incidence, and/or clinical outcomes. Sixteen studies were included describing the risk of gluten neuropathy and/or gluten ataxia in patients with CD. Gluten neuropathy was a neurological manifestation in CD (up to 39%) in 13 studies. Nine studies reported a lower risk and/or prevalence of gluten ataxia with a range of 0%–6%. Adherence to a gluten-free diet appeared to improve symptoms of both neuropathy and ataxia. The prevalence of gluten neuropathy and gluten ataxia in patients with CD varied in reported studies, but the increased risk supports the need for physicians to consider CD in patients with ataxia and neurological manifestations of unknown etiology.


2017 ◽  
Vol 117 (3) ◽  
pp. 719-727 ◽  
Author(s):  
Çiğdem Genç Sel ◽  
Erhan Aksoy ◽  
Ayşe Aksoy ◽  
Deniz Yüksel ◽  
Ferda Özbay

2017 ◽  
Vol 21 ◽  
pp. e114
Author(s):  
Ç Genç Sel ◽  
Erhan Aksoy ◽  
Ayşe Aksoy ◽  
Deniz Yüksel ◽  
Ferda Özbay

2015 ◽  
Vol 52 (3) ◽  
pp. 167-170 ◽  
Author(s):  
Sedat IŞIKAY ◽  
Halil KOCAMAZ

BackgroundSeveral neurological disorders have also been widely described in celiac disease patients.ObjectiveThe aim of this study was to determine the incidence of accompanying different neurologic manifestations in children with celiac disease at the time of diagnosis and to discuss these manifestations in the light of the recent literature.MethodsThis prospective cross sectional study included 297 children diagnosed with celiac disease. The medical records of all patients were reviewed.ResultsIn neurological evaluation, totally 40 (13. 5%) of the 297 celiac patients had a neurological finding including headache, epilepsy, migraine, mental retardation, breath holding spells, ataxia, cerebral palsy, attention deficit hyperactivity disorder, Down syndrome and Turner syndrome in order of frequency. There was not any significant difference between the laboratory data of the patients with and without neurological manifestations. However; type 3a biopsy was statistically significantly more common among patients without neurological manifestations, while type 3b biopsy was statistically significantly more common among patients with neurological manifestations.ConclusionIt is important to keep in mind that in clinical course of celiac disease different neurological manifestations may be reported.


2020 ◽  
Vol 4 (3) ◽  
pp. 1-15
Author(s):  
Cristóbal Coronel-Rodríguez ◽  
◽  
Alejandro Rodríguez-Martínez ◽  
◽  
◽  
...  

Sign in / Sign up

Export Citation Format

Share Document